News & Analysis as of

Controlled Substances Act Proposed Legislation DEA

Holland & Knight LLP

Congress Advances Cannabis and Hemp Proposals

Holland & Knight LLP on

Recent congressional activity highlights the changing environment for cannabis regulation. Specifically, U.S. Congress is moving forward with legislation that will change the regulation of hemp-derived products. The industry...more

Troutman Pepper

The Enemy of the Good: Comparing Administrative v. Legislative Approaches to Cannabis Reform

Troutman Pepper on

Only one day after reports surfaced that the Drug Enforcement Administration (DEA) will proceed with rescheduling cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), Senators Charles Schumer...more

McGlinchey Stafford

SAFER Act: Marijuana May Soon Become a Bigger Deal

McGlinchey Stafford on

Proponents of marijuana reform have had cause for celebration in 2023. Despite challenges facing the industry, the political and social momentum surrounding cannabis is ticking upward. Most recently, the marijuana industry...more

Vicente LLP

President Biden's Cannabis Scheduling Directive Is a Game Changer

Vicente LLP on

Most commentary I’ve seen on President Biden’s recently announced “three steps to end [the federal government’s] failed approach” to cannabis focuses primarily (often nearly entirely) on his decision to pardon all federal...more

Benesch

Ohio House of Representatives Passes Bill Regulating the Processing and Sale of Kratom Products

Benesch on

House Bill 236, which has passed the Ohio House of Representatives, would regulate the processing of kratom and the sale of kratom products in Ohio. With House Bill 236’s enactment, Ohio would become the sixth state to...more

Sheppard Mullin Richter & Hampton LLP

Cannabis Gets Go-Ahead from House, But Still Faces Hurdles Before Federal Legalization

On Friday, the United States House of Representatives voted to approve The Marijuana Opportunity and Expungement Act (MORE Act), which would decriminalize cannabis. This vote marks the first time that a chamber of Congress...more

Burns & Levinson LLP

The Path to Greenlighting CBD

Burns & Levinson LLP on

Last week, the industry was energized by the Drug Enforcement Administration’s order placing certain drugs containing cannabidiol, or CBD, in Schedule V of the Controlled Substances Act. This marks the first time in history...more

McGuireWoods LLP

Washington Healthcare Update

McGuireWoods LLP on

This Week: President’s FY2016 Budget Request... FDA Commissioner Hamburg to step down... Tennessee Medicaid expansion plan rejected by legislature. 1. Congress House House Ways and Means Committee Hosts Hearing...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide